The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 20, Issue 4, 2013, Pages 265-270

  Zipris, Danny ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

inflammation; innate immunity; intestine; Kilham rat virus; microbiota; type 1 diabetes

Indexed keywords

AUTOIMMUNITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; HEREDITY; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE FLORA; MICROBIOME; MOLECULAR INTERACTION; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW;

ANIMALS; DIABETES MELLITUS, TYPE 1; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; INSULIN; INTESTINES; MICROBIOTA;

EID: 84880315571     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e3283628569     Document Type: Review

References (63)

1. Zipris D. Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms. Clin Immunol 2009; 131:11-23.
2. The DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide. Diabetes Med 2006; 23:857-866.
3. Kontiainen S, Scheinin T, Schlenzka A, et al. Differences in HLA types in children with insulin-dependent diabetes diagnosed in 1960s, 1970s, and 1980s. Lancet 1988; 332:219.
4. Vehik K, Haller MJ, Beam CA, et al. Islet autoantibody seroconversion in the DPT-1 study. Diabetes Care 2011; 34:358-362.
5. King ML, Shaikh A, Bidwell D, et al. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet 1983; 1:1397-1399.
6. Szopa TM, Titchener PA, Portwood ND, Taylor KW. Diabetes mellitus due to viruses: some recent developments. Diabetologia 1993; 36:687-695.
7. Hara N, Alkanani AK, Ir D, et al. Prevention of virus-induced type 1 diabetes with antibiotic therapy. J Immunol 2012; 189:3805-3814.
8. Hara N, Alkanani AK, Ir D, et al. The role of the intestinal microbiota in type 1 diabetes. Clin Immunol 2013; 146:112-119.
9. Zipris D. Innate immunity and its role in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes 2008; 15:326-331.
10. Zipris D. Toll-like receptors and type 1 diabetes. Adv Exp Med Biol 2010; 654:585-610.
11. Schulte BM, Lanke KHW, Piganelli JD, et al. Cytokine and chemokine production by human pancreatic islets upon enterovirus infection. Diabetes 2012; 61:2030-2036.
12. Zipris D. Innate immunity in type 1 diabetes. Diabetes Metab Res Rev 2011; 27:824-829.
13. Honda K, Littman DR. The microbiomein infectious disease and inflammation. Annu Rev Immunol 2012; 30:759-795.
14. Dotta F, Censini S, van Halteren AGS, et al. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc Natl Acad Sci USA 2007; 104:5115-5120.
15. King ML, Bidwell D, Voller A, et al. Role of Coxsackie B viruses in insulin-dependent diabetes mellitus. Lancet 1983; 2:915-916.
16. Banatvala JE, Bryant J, Schernthaner G, et al. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1985; 1:1409-1412.
17. Dotta F, Galleri L, Sebastiani G, Vendrame F. Virus infections: lessons from pancreas histology. Curr Diabetes Rep 2010; 10:357-361.
18. Richardson SJ, Willcox A, Bone AJ, et al. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52:1143-1151.
19. Roep BO, Kleijwegt FS, Van Halteren AGS, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 2010; 159:338-343.
20. Ylipaasto P, Klingel K, Lindberg AM, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 2004; 47:225-239.
21. Yoon JW, Austin M, Onodera T, Notkins AL. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 1979; 300:1173-1179.
22. Tanaka S, Nishida Y, Aida K, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes 2009; 58:2285-2291.
23. Frigerio S, Junt T, Lu B, et al. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat Med 2002; 8:1414-1420.
24. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and [beta]-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5:219-226.
25. Clemente J, Ursell L, Parfrey L, Knight R. The impact of the gut microbiota on human health. An integrative view. Cell 2012; 148:1258-1270.
26. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101: 15718-15723.
27. Gill SR, Pop M, DeBoy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355-1359.
28. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010; 10:735-744.
29. Dave M, Higgins PD, Middha S, Rioux KP. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 2012; 160:246-257.
30. Dominguez-Bello MG, Blaser MJ, Ley RE, Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 2011; 140:1713-1719.
31. Frank DN, Pace NR. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 2008; 24:4-10.
32. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9:313-323.
33. Eloe-Fadrosh EA, Rasko DA. The human microbiome: from symbiosis to pathogenesis. Annu Rev Med 2013; 64:145-163.
34. Turnbaugh PJ, Quince C, Faith JJ, et al. Organismal, genetic, and transcrip-tional variation in the deeply sequenced gut microbiomes of identical twins. PNAS 2010; 107:7503-7508.
35. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-1638.
36. Ley RE, Lozupone CA, Hamady M, et al. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Micro 2008; 6:776-788.
37. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
38. Sonnenberg G, Artis D. Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease. Immunity 2012; 37:601-610.
39. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010; 140:859-870.
40. Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 2010; 10:159-169.
41. Vaahtovuo J, Munukka E, Korkeamaki M, et al. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008; 35:1500-1505.
42. Chervonsky A. Innate receptors and microbes in induction of autoimmunity. Curr Opin Immunol 2009; 21:641-647.
43. Frank DN, St. Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. PNAS 2007; 104:13780-13785.
44. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7:688-693.
45. Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol 2011; 11:9-20.
46. Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:179-184.
47. Li E, Hamm CM, Gulati AS, et al. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One 2012; 7:e26284.
48. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010; 330:1768-1773.
49. Aziz Q, Dore J, Emmanuel A, et al. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil 2013; 25:4-15.
50. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488:178-184.
51. van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368:407-415.
52. Hord NG. Eukaryotic-microbiota crosstalk: potential mechanisms for health benefits of prebiotics and probiotics. Annu Rev Nutr 2008; 28:215-231.
53. de Goffau MC, Luopajarvi K, Knip M, et al. Fecal microbiota composition differs between children with b-cell autoimmunity and those without. Diabetes 2013; 62:1238-1244.
54. Giongo A, Gano KA, Crabb DB, et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J 2011; 5:82-91.
55. Vaarala O, Atkinson MA, Neu J. The perfect storm' for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mu-cosal immunity. Diabetes 2008; 57:2555-2562.
56. Wen L, Ley RE, Volchkov PY, et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 2008; 455:1109-1113.
57. Markle JGM, Frank DN, Mortin-Toth S, et al. Sex Differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013; 339:1084-1088.
58. Brugman S, Klatter FA, Visser JT, et al. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involvedinthe developmentoftype1 diabetes? Diabetologia 2006; 49:2105-2108.
59. Roesch LF, Lorca GL, Casella G, et al. Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. ISME J 2009; 3:536-548.
60. Valladares R, Sankar D, Li N, et al. Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One 2010; 5:e10507.
61. Lau K, Benitez P, Ardissone A, et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol 2011; 186:3538-3546.
62. Zipris D, Lien E, Nair A, et al. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J Immunol 2007; 178:693-701.
63. Abt MC, Osborne LC, Monticelli L-A, et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012; 37:158-170.